Content:
Tổng quan
Nội dung của trang này:
Tổng quan
Nội dung của trang này:
Tổng quan
Tổng quan
Osteoporosis is a progressive, systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration of bone tissue leading to increased bone fragility and susceptibility to fractures.
Osteoporosis is often asymptomatic until patient presents with a fragility fracture.
Screening for osteoporosis is recommended for all postmenopausal women, men ≥50 years and adults with risk factors.
The choice of the drug will depend not only on its capacity to increase bone mineral density (BMD) but also on reducing spine and hip fracture.
For further information regarding the management of Osteoporosis, please refer to Disease Algorithm for the Treatment Guideline.
Osteoporosis is often asymptomatic until patient presents with a fragility fracture.
Screening for osteoporosis is recommended for all postmenopausal women, men ≥50 years and adults with risk factors.
The choice of the drug will depend not only on its capacity to increase bone mineral density (BMD) but also on reducing spine and hip fracture.
For further information regarding the management of Osteoporosis, please refer to Disease Algorithm for the Treatment Guideline.
